JLK Stock Jumps 11% on AI Software Deal with Hallym University Hospital

JLK (322510.KQ) shares surged 11% after the company announced an artificial intelligence subscription service contract with Hallym University Sacred Heart Hospital.

JLK's stock closed at 5,230 won on Monday, up 510 won (10.81%) from the previous session, according to Korea Exchange data. The rally came after the company said it would supply brain imaging AI software to the hospital under a subscription model.

JLK will provide four digital medical device software products approved by the Ministry of Food and Drug Safety: JLK-LVO, JLK-CTP, JLK-CTL, and JLK-PWI.

JLK-LVO uses AI to analyze brain computed tomography angiography (CTA) images to identify large vessel occlusion (LVO) and automatically assess suspected occlusion locations and vessel volume. The software was designated for integrated innovative medical device review in April and is currently undergoing procedures to obtain non-reimbursable pricing.

JLK-CTP and JLK-PWI calculate the volume of infarct core and hypoperfusion regions based on brain computed tomography perfusion (CTP) and magnetic resonance imaging (MRI), respectively, providing mismatch data between the two measurements. JLK-CTL automatically analyzes hypodensity regions in non-contrast computed tomography (NCCT) to provide brain imaging information.

"Hallym University Sacred Heart Hospital is actively adopting advanced AI solutions as part of its strategy to build a 'smart hospital,'" said Lee Min-woo, a professor of neurology at the hospital. "This adoption will help achieve our mid-to-long-term innovation goals of becoming a top-tier hospital by implementing patient-centered care and expanding the foundation for creative research and education activities by medical staff."

"This contract is significant as it is a subscription model that allows hospitals to continuously use AI software for a set period," said Kim Dong-min, CEO of JLK. "Based on a structure that enables regular updates and maintenance, medical institutions can adopt AI solutions without initial burden, and we expect this to spread to hospitals across Korea."